23andMe Holding Co (ME)
0.50
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
0.50
0.00 (0.00%)
After-Hours: 20:00
23andMe Revenue (TTM): 247.99M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 247.99M |
| September 30, 2023 | 270.18M |
| June 30, 2023 | 295.84M |
| March 31, 2023 | 299.49M |
| December 31, 2022 | 307.67M |
| September 30, 2022 | 297.62M |
| Date | Value |
|---|---|
| June 30, 2022 | 277.17M |
| March 31, 2022 | 271.89M |
| December 31, 2021 | 259.92M |
| September 30, 2021 | 258.50M |
| June 30, 2021 | 255.10M |
| March 31, 2021 | 243.92M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
243.92M
Minimum
Mar 2021
307.67M
Maximum
Dec 2022
273.77M
Average
271.04M
Median
Revenue (TTM) Benchmarks
| RadNet Inc | 1.617B |
| DermTech Inc | 15.30M |
| iSpecimen Inc | 9.928M |
| Sera Prognostics Inc | 0.306M |
| Invitae Corp | 481.58M |